Cargando…

Diagnosis of Inherited Platelet Disorders on a Blood Smear

Inherited platelet disorders (IPDs) are rare diseases featured by low platelet count and defective platelet function. Patients have variable bleeding diathesis and sometimes additional features that can be congenital or acquired. Identification of an IPD is desirable to avoid misdiagnosis of immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaninetti, Carlo, Greinacher, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074415/
https://www.ncbi.nlm.nih.gov/pubmed/32079152
http://dx.doi.org/10.3390/jcm9020539
_version_ 1783506828029591552
author Zaninetti, Carlo
Greinacher, Andreas
author_facet Zaninetti, Carlo
Greinacher, Andreas
author_sort Zaninetti, Carlo
collection PubMed
description Inherited platelet disorders (IPDs) are rare diseases featured by low platelet count and defective platelet function. Patients have variable bleeding diathesis and sometimes additional features that can be congenital or acquired. Identification of an IPD is desirable to avoid misdiagnosis of immune thrombocytopenia and the use of improper treatments. Diagnostic tools include platelet function studies and genetic testing. The latter can be challenging as the correlation of its outcomes with phenotype is not easy. The immune-morphological evaluation of blood smears (by light- and immunofluorescence microscopy) represents a reliable method to phenotype subjects with suspected IPD. It is relatively cheap, not excessively time-consuming and applicable to shipped samples. In some forms, it can provide a diagnosis by itself, as for MYH9-RD, or in addition to other first-line tests as aggregometry or flow cytometry. In regard to genetic testing, it can guide specific sequencing. Since only minimal amounts of blood are needed for the preparation of blood smears, it can be used to characterize thrombocytopenia in pediatric patients and even newborns further. In principle, it is based on visualizing alterations in the distribution of proteins, which result from specific genetic mutations by using monoclonal antibodies. It can be applied to identify deficiencies in membrane proteins, disturbed distribution of cytoskeletal proteins, and alpha as well as delta granules. On the other hand, mutations associated with impaired signal transduction are difficult to identify by immunofluorescence of blood smears. This review summarizes technical aspects and the main diagnostic patterns achievable by this method.
format Online
Article
Text
id pubmed-7074415
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70744152020-03-20 Diagnosis of Inherited Platelet Disorders on a Blood Smear Zaninetti, Carlo Greinacher, Andreas J Clin Med Article Inherited platelet disorders (IPDs) are rare diseases featured by low platelet count and defective platelet function. Patients have variable bleeding diathesis and sometimes additional features that can be congenital or acquired. Identification of an IPD is desirable to avoid misdiagnosis of immune thrombocytopenia and the use of improper treatments. Diagnostic tools include platelet function studies and genetic testing. The latter can be challenging as the correlation of its outcomes with phenotype is not easy. The immune-morphological evaluation of blood smears (by light- and immunofluorescence microscopy) represents a reliable method to phenotype subjects with suspected IPD. It is relatively cheap, not excessively time-consuming and applicable to shipped samples. In some forms, it can provide a diagnosis by itself, as for MYH9-RD, or in addition to other first-line tests as aggregometry or flow cytometry. In regard to genetic testing, it can guide specific sequencing. Since only minimal amounts of blood are needed for the preparation of blood smears, it can be used to characterize thrombocytopenia in pediatric patients and even newborns further. In principle, it is based on visualizing alterations in the distribution of proteins, which result from specific genetic mutations by using monoclonal antibodies. It can be applied to identify deficiencies in membrane proteins, disturbed distribution of cytoskeletal proteins, and alpha as well as delta granules. On the other hand, mutations associated with impaired signal transduction are difficult to identify by immunofluorescence of blood smears. This review summarizes technical aspects and the main diagnostic patterns achievable by this method. MDPI 2020-02-17 /pmc/articles/PMC7074415/ /pubmed/32079152 http://dx.doi.org/10.3390/jcm9020539 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zaninetti, Carlo
Greinacher, Andreas
Diagnosis of Inherited Platelet Disorders on a Blood Smear
title Diagnosis of Inherited Platelet Disorders on a Blood Smear
title_full Diagnosis of Inherited Platelet Disorders on a Blood Smear
title_fullStr Diagnosis of Inherited Platelet Disorders on a Blood Smear
title_full_unstemmed Diagnosis of Inherited Platelet Disorders on a Blood Smear
title_short Diagnosis of Inherited Platelet Disorders on a Blood Smear
title_sort diagnosis of inherited platelet disorders on a blood smear
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074415/
https://www.ncbi.nlm.nih.gov/pubmed/32079152
http://dx.doi.org/10.3390/jcm9020539
work_keys_str_mv AT zaninetticarlo diagnosisofinheritedplateletdisordersonabloodsmear
AT greinacherandreas diagnosisofinheritedplateletdisordersonabloodsmear